Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE

PURPOSE: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant is approved in the United Arab Emirates (UAE) for treating diabetic macular edema (DME) in patients previously treated with a course of corticosteroids and that did not have a clinically significant rise in intraocular pressure (...

Descripción completa

Detalles Bibliográficos
Autor principal: Elbarky, Ahmed Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083643/
https://www.ncbi.nlm.nih.gov/pubmed/32214793
http://dx.doi.org/10.2147/OPTH.S238740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083643/
https://www.ncbi.nlm.nih.gov/pubmed/32214793
http://dx.doi.org/10.2147/OPTH.S238740

Ejemplares similares